Evidence map›Paper›PMID 18547195›Full record

ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2008

Understanding incidental findings in the context of genetics and genomics.

Mildred K Cho

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01568684 (Pharmacogenetics and Neuroimaging in Major Depressive Disorder), which is not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01568684 phase1withdrawnnot on this mapstarted 2012, after this paper: background citation

Pharmacogenetics and Neuroimaging in Major Depressive Disorder (PAN-D)

TypeinterventionalSponsorNational Institute of Mental Health (NIMH)Ran2012 to 2012Enrolled0ConditionsDepressive Disorder, Depressive Disorder, Major, DepressionArmsCitalopram
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Privacy and ethical challenges in next-generation sequencing.Expert review of precision medicine and drug development · 2019
    Article
  10. Article
  11. Article
  12. Next-Generation Sequencing and the Return of Results.Cold Spring Harbor perspectives in medicine · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. To disclose, or not to disclose? Context matters.European journal of human genetics : EJHG · 2015
    Article
  18. Automatic Placement of Genomic Research Results in Medical Records: Do Researchers Have a Duty? Should Participants Have a Choice?The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2015
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mildred K ChoDepartment of Pediatrics at Stanford University, CA, USA.

Funding

Center for Integration of Research on Genetics and EthicsP50HG003389 · NHGRI · STANFORD UNIVERSITY · PI CHO, MILDRED K. · 2004 to 2014
$9.9M
Managing Incidental Findings in Human Subjects ResearchR01HG003178 · NHGRI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WOLF, SUSAN M. · 2005 to 2010
$1.5M
NHGRI NIH HHS 5 P50 HG 3389-04NHGRI NIH HHS P50 HG003389NHGRI NIH HHS R01 HG 003178NHGRI NIH HHS R01 HG003178
6 · The paper itself

Abstract

Human genetic and genomic research can yield information that may be of clinical relevance to the individuals who participate as subjects of the research. It has been common practice among researchers to notify participants during the informed consent process that no individual results will be disclosed, "incidental" or otherwise. However, as genetic information obtained in research becomes orders of magnitude more voluminous, increasingly accessible online, and more informative, this precedent may no longer be appropriate. There is not yet consensus on the responsibilities of researchers to disclose individual research results to research participants. Empirical research suggests that participants want to know individual research results. On the other hand, the increased resolution and power afforded by new genomic analyses may lead to findings of statistical, but not necessarily clinical, significance. This paper addresses the issues to be considered in deciding whether and how to disclose "incidental" findings or other findings of clinical significance that arise in the course of human genomic and genetic research. What research results should be offered, and what should not be offered? For which research should individual results be offered to research participants, when should they be offered, how, and to whom?

Indexed as

DisclosureIncidental FindingsGenetic ResearchGenomicsHumansResearcher-Subject Relations

Identifiers

PMID18547195
PMCPMC2581745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.